ITOS (iteostherapeutics.com) Bozor qiymatining balans qiymatiga nisbati
iTeos Therapeutics (ITOS) kapitalni himoya qilish uchun GSK bilan hamkorligidan foydalangan holda, o'smalarga qarshi kurashishning eng zamonaviy usullarini ishlab chiqmoqda. Joriy narxning buxgalteriya qiymatiga nisbati bozor konsensusini aks ettiradi, bunda parametr 0.91 ga tengdir. Shu bilan birga, kompaniya o'z laboratoriyalarida energiyani tejash va emissiyalarni filtrlashni joriy qilmoqda. Yuqori ilmiy nufuz va onkologlarning ishonchi brendga investorlarning barqaror qo'llab-quvvatlashini ta'minlaydi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ITOS_-_iTeos-Therapeutics_-_Market-Capitalization-to-Net-Assets "ITOS iTeos Pharma Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 14.09.2025) | 👁️GURU.Markets👁️")
iTeos Therapeutics Inc (ITOS) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:iTeos Therapeutics - ITOS
Ushbu koeffitsiyent aktivlarning bozor qiymatini ularning balans qiymatiga solishtirib, kelajakdagi o'sish uchun haqiqiy premiumni ochib beradi. iTeos Therapeutics (ITOS) uchun bozor qiymatining kapitalizatsiya balans qiymatiga nisbati o'zgarishi investorlarning kompaniyaning immuno-onkologiya ishlanmalari potensialiga bo'lgan ishonchini aks ettiradi. Ushbu tendentsiya bozor texnologik platformani joriy xarajatlardan qanchalik yuqori baholashini ko'rsatadi. Silliq tendentsiya biznesning fundamental barqarorligini tasdiqlaydi; biroq, haddan tashqari katta farq kutublar korreksiyasi yuz berganda xatarlarning ortganidan signal beradi.
Asosiy raqobatchilar
argenx SE - Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati RIGL (Rigel Pharmaceuticals Inc)|AnaptysBio Inc. (ANAB) - Balans qiymatiga nisbatan bozor kapitallashuvi|ATXS - Kapitallashuvning sof aktivlarga nisbati|engene.com (ENGN) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati RAPT (RAPT Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti JBIO|Aclaris - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti KYTX (Kyverna Therapeutics, Inc)|Bozor qiymatining balans qiymatiga nisbati TLSA|CABA - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Ventyx Biosciences, Inc. (VTYX)|Theratechnologies, Inc. (THTX) - Balans qiymatiga nisbatan bozor qiymati|AVTX - Kapitallashuvning sof aktivlarga nisbati|Eledon Pharmaceuticals, Inc (ELDN) - Bozor kapitallashuvining balans qiymatiga multiplikatori|AGEN - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati climbbio.com|Zura Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ATYR (aTyr Pharma Inc)|Bozor qiymatining balans qiymatiga nisbati Adagene Inc.|Balans qiymatiga nisbatan bozor qiymati ImageneBio IMA|Shattuck Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|EQ: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati connectbiopharm.com (CNTB)|Immunic (IMUX) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ATRA (Atara Biotherapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti InflaRx GmbH (IFRX)|Kapitallashuvning sof aktivlarga nisbati XFOR|Bozor kapitallashuvining balans qiymatiga nisbati adicetbio.com ACET|Kapitallashuvning sof aktivlarga nisbati Celularity (CELU)|Bozor kapitallashuvining balans qiymatiga multiplikatori INmune Bio Inc INMB|Bozor kapitallashuvining balans qiymatiga nisbati BRNS (Barinthus Bio)|KZR - Balans qiymatiga nisbatan bozor kapitallashuvi|SABS (SAB Biotherapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|AKTX (akaritx.com) - Kapitallashuvning sof aktivlarga nisbati|ENLV: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Q32 Bio Corp|GOVX (GeoVax Labs Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Edesa Biotech Corp EDSA|Kapitallashuvning sof aktivlarga nisbati iBio, Inc. (IBIO)|Carisma Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga multiplikatori|XTLB (XTL Biopharmaceuticals Ltd.) - Bozor qiymatining balans qiymatiga nisbati|BOLT: Bozor qiymatining balans qiymatiga koeffitsiyenti|hcwbiologics.com - Bozor qiymatining balans qiymatiga nisbati|APVO (Aptevo Therapeutics Inc.) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AIM ImmunoTech Inc. AIM|Sof aktivlarga nisbatan bozor kapitallashuvi Aditxt Corp|GRI Bio (GRI) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati XORTX Therapeutics Inc (XRTX)|Bozor kapitallashuvining balans qiymatiga nisbati HIND (ReShape Lifesciences)|Revelation Biosciences Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Indaptus Therapeutics (INDP)|SCNI: Balans qiymatiga nisbatan bozor qiymati|CALI (calcimedica.com) - Bozor qiymatining balans qiymatiga nisbati|Affimed N.V. (AFMD) - Kapitallashuvning sof aktivlarga nisbati|ALLK (Allakos Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati HOOKIPA (HOOK)|IGM Biosciences, Inc. (IGMS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi